ES2176330T3 - Compuestos y composiciones para administracion por inhalacion oral o insuflacion. - Google Patents

Compuestos y composiciones para administracion por inhalacion oral o insuflacion.

Info

Publication number
ES2176330T3
ES2176330T3 ES95920874T ES95920874T ES2176330T3 ES 2176330 T3 ES2176330 T3 ES 2176330T3 ES 95920874 T ES95920874 T ES 95920874T ES 95920874 T ES95920874 T ES 95920874T ES 2176330 T3 ES2176330 T3 ES 2176330T3
Authority
ES
Spain
Prior art keywords
insuflation
administration
compositions
compounds
oral inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95920874T
Other languages
English (en)
Inventor
Constantin Efthymiopoulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biota Scientific Management Pty Ltd
Original Assignee
Biota Scientific Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scientific Management Pty Ltd filed Critical Biota Scientific Management Pty Ltd
Application granted granted Critical
Publication of ES2176330T3 publication Critical patent/ES2176330T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

EL ACIDO 5-ACETAMIDO-2,2,4,5-TETRADEOXI-4-GUANIDINO- -}DGLICERO-{SUB,}D- GALACTO-NO-2-ENOPIRANOSONICO MUESTRA ACTIVIDAD ANTIVIRAL EN ANIMALES, ESPECIALMENTE HUMANOS, CUANDO SE ADMINISTRA BUCALMENTE MEDIANTE INHALACION O INSUFLACION.
ES95920874T 1994-05-28 1995-05-24 Compuestos y composiciones para administracion por inhalacion oral o insuflacion. Expired - Lifetime ES2176330T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9410817A GB9410817D0 (en) 1994-05-28 1994-05-28 Medicaments

Publications (1)

Publication Number Publication Date
ES2176330T3 true ES2176330T3 (es) 2002-12-01

Family

ID=10755922

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95920874T Expired - Lifetime ES2176330T3 (es) 1994-05-28 1995-05-24 Compuestos y composiciones para administracion por inhalacion oral o insuflacion.

Country Status (12)

Country Link
EP (1) EP0764023B1 (es)
JP (1) JPH10500966A (es)
AT (1) ATE221778T1 (es)
AU (1) AU701590B2 (es)
DE (1) DE69527713T2 (es)
DK (1) DK0764023T3 (es)
ES (1) ES2176330T3 (es)
GB (1) GB9410817D0 (es)
IL (1) IL113879A (es)
PT (1) PT764023E (es)
WO (1) WO1995032712A1 (es)
ZA (1) ZA954331B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
BR9607098B8 (pt) 1995-02-27 2014-11-18 Gilead Sciences Inc Composto e composição farmacêutica.
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US5859284A (en) 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
NZ335368A (en) 1996-11-14 2001-08-31 Biota Scient Management Macromolecular compound with one or more neuraminidase binders, binds to the active site of influenza virus neuraminidase
AU5546898A (en) * 1997-01-14 1998-08-07 Hopital Sainte-Justine Human lysosomal sialidase and therapeutic uses thereof
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
US20130251790A1 (en) 2010-09-27 2013-09-26 Cipla Limited Low Dose Pharmaceutical Composition Comprising Zanamivir

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01287029A (ja) * 1988-05-13 1989-11-17 Mect Corp 新規抗ウィルス剤
CZ288492B6 (en) * 1990-04-24 2001-06-13 Biota Scient Management Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
CA2081068C (en) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid

Also Published As

Publication number Publication date
IL113879A (en) 2001-01-11
PT764023E (pt) 2002-12-31
DE69527713D1 (de) 2002-09-12
EP0764023A1 (en) 1997-03-26
AU2615795A (en) 1995-12-21
EP0764023B1 (en) 2002-08-07
IL113879A0 (en) 1995-08-31
AU701590B2 (en) 1999-02-04
JPH10500966A (ja) 1998-01-27
ZA954331B (en) 1996-01-29
ATE221778T1 (de) 2002-08-15
WO1995032712A1 (en) 1995-12-07
DE69527713T2 (de) 2003-04-10
GB9410817D0 (en) 1994-07-20
DK0764023T3 (da) 2002-11-18

Similar Documents

Publication Publication Date Title
EP0509317A3 (en) Use of droloxifene in the treatment of bone diseases
FI945882A0 (fi) Uudet biaromaattiset propynyyliyhdisteet, niitä sisältävät farmaseuttiset ja kosmetiikkakoostumukset sekä niiden käyttö
ATE99941T1 (de) Medikamente enthaltend salmeterol und fluticason.
DE69532415D1 (de) Schmelzextrudierte oral verabreichbare opioidformulierungen
DE69223914D1 (de) 4-substituierte-2-Deoxy-2,3-Didehydro Alpha-D-Neuraminsäure antivirale Derivate
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
DE69529670D1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
BR0013010A (pt) Formulação de cloreto de sódio de moxifloxacina
DE69429964D1 (de) Feste, therapeutische oder hygienische, mucoadhäsive Zusammensetzung zur Verabreichung durch Auftragen auf der Mund-schleimhaut oder der Nasen-schleimhaut
ES2176330T3 (es) Compuestos y composiciones para administracion por inhalacion oral o insuflacion.
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
DK0538011T3 (da) Saltsammensætninger omfattende lipofilt oligosaccharidantibiotikum.
ATE318575T1 (de) Orale zubereitung chlorhexidin und maltitol oder erythritol oder deren mischung enthaltend
DE69918961D1 (de) Verbesserte inhalationspräparate
HUT74619A (en) Veterinary composition of anesthetic activity
WO1999050239A3 (fr) Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant
GB9126874D0 (en) Medicaments
SG28346G (en) Medicaments for the treatment of toxoplasmosis
DE69719190D1 (de) Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
DE69008282D1 (de) Kaffeesäure-Derivate, deren Verwendung für medizinische Behandlungen und diese enthaltende pharmazeutische Zusammensetzungen.
IL87867A0 (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-pyridine derivatives
IT8419846A0 (it) Composizione di presidi per la disinfezione e la sterilizzazione ambientale, in particolare strumenti chirurgici, endoscopici, dentistici e per anestesia.